Delta opioid receptor agonist reduces anxiety-like behavior in mice

Anxiety-related disorders can have a profound impact on the mental health and quality of life of affected individuals.

China’s NMPA approves Zai Lab’s XACDURO NDA for pneumonia

Treatment with XACDURO was found to be well-tolerated with a favourable safety profile across the clinical programme. Credit: fizkes / Shutterstock.com. Zai Lab and Innoviva

May 20, 2024

New communication tool reduces sick leave in patients with Medically Unexplained Physical Symptoms

Medically Unexplained Physical Symptoms (MUPS) are characterized by persistent bodily symptoms and functional impairment that lack an explanation through known medical condition or pathology.

October 17, 2023

Abridge Raises $250M to Advance AI-Powered Clinical Documentation

What You Should Know: – Abridge, a provider of generative AI solutions for healthcare, today announced a $250M Series D funding round, bringing its total

February 18, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.